Transdermal nicotine replacement therapy in cigarette smokers with acute subarachnoid hemorrhage

Neurocritical Care

Volumn 14, Issue 1, 2011, Pages 77-83

  Seder, David B ^b   Schmidt, J Michael ^a   Badjatia, Neeraj ^a   Fernandez, Luis ^a   Rincon, Fred ^a   Claassen, Jan ^a   Gordon, Errol ^a   Carrera, Emmanuel ^a   Kurtz, Pedro ^a   Lee, Kiwon ^a   Connolly, E Sander ^a   Mayer, Stephan A ^a  

^a Department of Orthopaedic Surgery   (United States)

^b NONE

Author keywords

Aneurysm; Hemorrhagic stroke; Neurocritical care; Nicotine; Subarachnoid hemorrhage

Indexed keywords

NICOTINE;

ADULT; ALCOHOL CONSUMPTION; ANEMIA; APACHE; ARTICLE; BLEEDING; BRAIN ANGIOGRAPHY; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN VASOSPASM; CIGARETTE SMOKING; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DELIRIUM; DIABETES MELLITUS; DOPPLER ECHOGRAPHY; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; FEVER; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERGLYCEMIA; HYPERNATREMIA; HYPONATREMIA; HYPOTENSION; INTENSIVE CARE UNIT; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCORING SYSTEM; SEIZURE; SUBARACHNOID HEMORRHAGE;

ACUTE DISEASE; ADMINISTRATION, CUTANEOUS; ADULT; AGED; CRITICAL CARE; DATABASES, FACTUAL; DELIRIUM; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPROTECTIVE AGENTS; NICOTINE; NICOTINIC AGONISTS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SUBARACHNOID HEMORRHAGE; VASOSPASM, INTRACRANIAL;

EID: 79551514704     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12028-010-9456-9     Document Type: Article

References (48)

1. CS Anderson V Feigin D Bennett, et al. 2004 Active and passive smoking and the risk of subarachnoid hemorrhage Stroke 35 633 637 10.1161/01.STR. 0000115751.45473.48 14752125 (Pubitemid 38280832)
2. BKA Weir GL Kongable NF Kassell, et al. 1998 Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study J Neurosurg 89 405 411 1:STN:280:DyaK1czovFGjtQ%3D%3D 10.3171/jns.1998.89.3.0405 9724114
3. LOD Koskinen PC Blomstedt 2006 Smoking and non-smoking tobacco as risk factors in subarachnoid hemorrhage Acta Neurol Scand 114 33 37 10.1111/j.1600-0404.2006.00591.x 16774625 (Pubitemid 43879756)
4. TM Lasner RJ Weil HA Riina, et al. 1997 Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage J Neurosurg 87 381 384 1:STN:280:DyaK2svivF2ltg%3D%3D 10.3171/jns.1997.87.3.0381 9285602
5. S Krishnamurthy JP Kelleher EB Lehman KM Cockroft 2007 Effects of tobacco dose and length of exposure on delayed neurological deterioration and overall clinical outcome after aneurysmal subarachnoid hemorrhage Neurosurgery 61 475 481 10.1227/01.NEU.0000290892.46954.12 17881958
6. SA Mayer JY Chong E Ridgeway C Min C Commichau GL Bernardini 2001 Delirium from nicotine withdrawal in neuro-ICU patients Neurology 57 551 553 1:STN:280:DC%2BD3Mvlslaisg%3D%3D 11502936
7. J Ballard KT Kreiter J Claassen RG Kowalski ES Connolly SA Mayer 2003 Risk factors for continued cigarette use after subarachnoid hemorrhage Stroke 34 1859 1863 10.1161/01.STR.0000080522.36041.9F 12843355 (Pubitemid 36944769)
8. A Molyneux S Lewis U Leivers, et al. 2003 Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counseling alone, and minimal intervention on smoking cessation in hospital inpatients Thorax 58 484 488 1:STN:280:DC%2BD3s3os1eqtA%3D%3D 10.1136/thorax.58.6.484 12775857 (Pubitemid 36714008)
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association; 1994.
10. JL Rudolph RN Jones LS Rasmussen, et al. 2007 Independent vascular and cognitive risk factors for postoperative delirium Am J Med 120 9 807 813 10.1016/j.amjmed.2007.02.026 17765051 (Pubitemid 47313345)
11. EW Ely A Shintani B Truman, et al. 2004 Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit JAMA 291 1753 1762 1:CAS:528:DC%2BD2cXjt1Wrtbs%3D 10.1001/jama.291.14.1753 15082703 (Pubitemid 38489897)
12. EW Ely S Gautam R Margolin J Francis L May T Speroff B Truman R Dittus GR Bernard SK Inouye 2001 The impact of delirium in the intensive care unit on hospital length of stay Intensive Care Med 27 1892 1900 1:STN:280: DC%2BD38%2FntVKjtg%3D%3D 10.1007/s00134-001-1132-2 11797025 (Pubitemid 33145075)
13. EB Milbrandt S Deppen PL Harrison AK Shintani T Speroff RA Stiles B Truman GR Bernard RS Dittus EW Ely 2004 Costs associated with delirium in mechanically ventilated patients Crit Care Med 32 955 962 10.1097/01.CCM. 0000119429.16055.92 15071384 (Pubitemid 38471515)
14. JW Thomason A Shintani JF Peterson BT Pun JC Jackson EW Ely 2005 Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients Crit Care 9 R375 R381 10.1186/cc3729 16137350
15. F Huhtasaari K Asplund V Lundberg B Stegmayr PO Wester 1992 Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 305 1252 1256 1:STN:280:DyaK3s7itV2gtw%3D%3D 10.1136/bmj.305.6864.1252 1477567
16. F Huhtasaari V Lundberg M Eliasson U Janlert K Asplund 1999 Smokeless tobacco as a possible risk factor for myocardial infarction. A population based study in middle aged men J Am Coll Cardiol 34 1784 1790 1:STN:280: DC%2BD3c%2FktlGjsA%3D%3D 10.1016/S0735-1097(99)00409-X 10577570
17. AM Joseph SM Norman LH Ferry, et al. 1996 The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease N Engl J Med 335 1792 1798 1:CAS:528:DyaK2sXntlGn 10.1056/NEJM199612123352402 8943160 (Pubitemid 26412397)
18. TJ Meine MR Patel JB Washam PA Pappas JG Jollis 2005 Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes Am J Cardiol 95 976 978 1:CAS:528:DC%2BD2MXjtlWjurY%3D 10.1016/j.amjcard.2004.12.039 15820167 (Pubitemid 40487750)
19. NL Benowitz SG Gourlay 1997 Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy J Am Coll Cardiol 29 1422 1431 1:CAS:528:DyaK2sXktV2is7w%3D 10.1016/S0735-1097(97)00079-X 9180099 (Pubitemid 27272432)
20. AH Lee B Afessa 2007 The association of nicotine replacement therapy with mortality in a medical intensive care unit Crit Care Med 35 1517 1:CAS:528:DC%2BD2sXls1Gqsb8%3D 10.1097/01.CCM.0000266537.86437.38 17452926 (Pubitemid 46809315)
21. R Cartin-Ceba B Afessa 2009 Nicotine replacement therapy in critically ill patients: a prospective observational cohort study Crit Care Med 37 Supplement 12 A8
22. CA Paciullo MR Short DT Steinke HR Jennings 2009 Impact of nicotine replacement therapy on postoperative mortality following coronary artery bypass graft surgery Ann Pharmacother 43 1197 1202 1:CAS:528:DC%2BD1MXhtVWjt73P 10.1345/aph.1L423 19567657
23. H Mundal P Hjemdahl K Gjesdal 1995 Acute effects of low dose nicotine gum on platelet function in nonsmoking hypertensive and normotensive men Eur J Clin Pharmacol 47 411 416 1:STN:280:DyaK2M3jslamtQ%3D%3D 10.1007/BF00196854 7720762
24. NL Benowitz GA Fitzgerald M Wilson Q Zhang 1993 Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking J Am Coll Cardiol 22 1159 1167 1:CAS:528: DyaK2cXpvFajsw%3D%3D 10.1016/0735-1097(93)90431-Y 7691912
25. C Rangemark G Benthin EF Granstrom L Persson S Winell A Wennmalm 1992 Tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in women stratified by age Circulation 86 1495 1500 1:STN:280: DyaK3s%2FkslSqtA%3D%3D 1423963
26. 2+ channels in cerebral arterioles Circ Res 88 359
27. JW Davis L Shelton DA Eigenberg CE Hignite IS Watanabe 1985 Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets Clin Pharmacol Ther 37 529 533 1:STN:280:DyaL2M7nvVSjtA%3D%3D 10.1038/clpt.1985.83 3987176
28. SJ Lin CY Hong MS Chang BN Chiang S Chien 1992 Long-term nicotine exposure increases aortic endothelial cell death and enhances transendothelial macromolecular transport in rats Arterioscler Thromb 12 1305 1312 1:CAS:528:DyaK3sXnsFWqtg%3D%3D 1420090
29. J Claassen KT Kreiter RG Kowalski, et al. 2004 Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage Crit Care Med 32 832 838 10.1097/01.CCM.0000114830.48833.8A 15090970 (Pubitemid 38344142)
30. J Claassen JR Carhuapoma KT Kreiter, et al. 2002 Global cerebral edema after subarachnoid hemorrhage: frequency, predictors and impact on outcome Stroke 33 1225 1232 10.1161/01.STR.0000015624.29071.1F 11988595 (Pubitemid 34520392)
31. AM Naidech B Jovanovic KE Wartenberg, et al. 2007 Higher hemoglobin is associated with improved outcome after subarachnoid hemorrhage Crit Care Med 35 2383 2389 1:CAS:528:DC%2BD2sXhtVKhs73K 10.1097/01.CCM.0000284516.17580.2C 17717494 (Pubitemid 47476238)
32. JM Schmidt KE Wartenberg A Fernandez, et al. 2008 Frequency and clinical impact of asymptomatic cerebral infarction due to vasospasm after subarachnoid hemorrhage J Neurosurg 109 1052 1059 10.3171/JNS.2008.109.12.1052 19035719
33. SK Inouye CH van Dyck CA Alessi S Balkin AP Siegal RI Horwitz 1990 Clarifying confusion: the confusion assessment method: a new method for detection of delirium Ann Intern Med 113 941 948 1:STN:280: DyaK3M%2Flt1yisQ%3D%3D 2240918
34. KE Wartenberg JM Schmidt J Claassen, et al. 2006 Impact of medical complications on outcome after subarachnoid hemorrhage Crit Care Med 34 617 623 10.1097/00003246-200612002-00426 16521258
35. M Kox AW Hoedemaekers P Pickkers JG van der Hoeven JC Pompe 2007 A possible role for the cholinergic anti-inflammatory pathway in increased mortality observed in critically ill patients receiving nicotine replacement therapy Crit Care Med 35 10 2468 2469 10.1097/01.CCM.0000284498.88787.D7 17885405 (Pubitemid 47476278)
36. HC Bergstrom CG McDonald HT French RF Smith 2008 Continuous nicotine administration produces selective, age-dependent structural alteration of pyramidal neurons from prelimbic cortex Synapse 62 1 31 39 1:CAS:528: DC%2BD2sXhtl2nurfE 10.1002/syn.20467 17957736 (Pubitemid 350156141)
37. CG McDonald AK Eppolito JM Brielmaier LN Smith HC Bergstrom MR Lawhead RF Smith 2007 Evidence for elevated nicotine-induced structural plasticity in nucleus accumbens of adolescent rats Brain Res 1151 211 218 1:CAS:528: DC%2BD2sXlt1CjsL4%3D 10.1016/j.brainres.2007.03.019 17418110 (Pubitemid 46709878)
38. NL Benowitz 2008 Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction Clin Pharmacol Ther 83 531 541 1:CAS:528:DC%2BD1cXjsFCksrk%3D 10.1038/clpt.2008.3 18305452 (Pubitemid 351417076)
39. L Fratiglioni HX Wang 2000 Smoking and Parkinson's and Alzheimer's disease: review of the epidemiological studies Behav Brain Res 113 117 120 1:CAS:528:DC%2BD3cXlvFGmsLc%3D 10.1016/S0166-4328(00)00206-0 10942038 (Pubitemid 30645549)
40. MR Picciotto M Zoli 2008 Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease Front Biosci 13 492 504 1:CAS:528:DC%2BD1cXhs1Chtr8%3D 10.2741/2695 17981563 (Pubitemid 351599760)
41. KM Powers DM Kay SA Factor, et al. 2008 Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk Mov Disord 23 88 95 10.1002/mds.21782 17987647 (Pubitemid 351281223)
42. K Parain C Hapdey E Rousselet V Marchand B Dumery EC Hirsch 2003 Cigarette smoke and nicotine protect dopaminergic neurons against the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine Parkinsonian toxin Brain Res 984 224 232 1:CAS:528:DC%2BD3sXmsVKgurs%3D 10.1016/S0006-8993(03)03195-0 12932857 (Pubitemid 36976812)
43. M Quik T Bordia K O'Leary 2007 Nicotinic receptors as CNS targets for Parkinson's disease Biochem Pharmacol 74 1224 1234 1:CAS:528:DC%2BD2sXhtVOgu7nK 10.1016/j.bcp.2007.06.015 17631864 (Pubitemid 47417919)
44. RL Copeland Jr JR Das YM Kanaan RE Taylor Y Tizabi 2007 Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity Neurotox Res 12 61 69 1:CAS:528:DC%2BD2sXhtVSiu7fP 10.1007/BF03033901 17513200
45. A Akaike Y Tamura T Yokota S Shimohama J Kimura 1994 Nicotine-induced protection of cultured cortical neurons against N-methyl-d-aspartate receptor-mediated glutamate cytotoxicity Brain Res 644 181 187 1:CAS:528:DyaK2cXjtFOnu7w%3D 10.1016/0006-8993(94)91678-0 7519524 (Pubitemid 24127971)
46. P Marin M Maus S Desagher J Glowinski J Premont 1994 Nicotine protects cultured striatal neurons against N-methyl-d-aspartate receptor-mediated toxicity Neuroreport 5 1977 1980 1:CAS:528:DyaK2cXmvFens7g%3D 10.1097/00001756-199410000-00035 7841389
47. R Garrido A Malecki B Hennig M Toborek 2000 Nicotine attenuates arachadonic acid-induced neurotoxicity in cultured spinal cord neurons Brain Res 861 59 68 1:CAS:528:DC%2BD3cXit1WhsLo%3D 10.1016/S0006-8993(00)01977-6 10751565 (Pubitemid 30177283)
48. HJ Park PH Lee YW Ahn 2007 Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action Eur J Neurosci 26 79 89 10.1111/j.1460-9568.2007.05636.x 17581257 (Pubitemid 47035441)